AVIEW LCS PLUS

Chest Disease Solution

CAD

Artificial intelligence is used to find nodules,
analyze various information.

BIG 3

Disease solution that corresponds to
the top 3 causes of death by 2050
(lung cancer, COPD, cardiovascular disease)

FOLLOW-UP

Past and current studies can be compared
through non-rigid registration.

Product Description

AVIEW LCS PLUS
is an integrated solution for high-risk diseases such as lung cancer, COPD, and cardiovascular disease.

Follow-up

Current & Previous Comparison

Through non-rigid registration, compare and analyze past and present data, and check nodule change information over time for all nodule types.

Follow-up

Volume Doubling Time

The prognosis of lung cancer can be determined by analyzing the time when the nodule volume doubles.